Clinical Trial Update: Memantine for Treatment of Cognitive Impairment in Patients With Parkinson's Disease and Dementia [NA]

View source ↗

Summary

A completed clinical trial evaluating memantine for cognitive impairment in Parkinson's disease and dementia; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Dementia
• Parkinson Disease

Drugs mentioned

• Memantine (memantine)

Snippet

Sponsor: Johns Hopkins University | Conditions: Parkinson's Disease, Cognitive Impairment | NA | Status: COMPLETED | Results posted: 2017-09-12